# Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)

> **NCT00662779** · PHASE3 · WITHDRAWN · sponsor: **University of New Mexico**

## Conditions studied

- Exercise-induced Bronchospasm

## Interventions

- **DRUG:** arformoterol
- **DRUG:** formoterol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00662779
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** High number of screen failures-couldn't find qualified subjects in timely manner
- **Last updated:** 2015-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662779, "Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00662779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*